Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14351-14400 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04494945
Identifying and Caring for Individuals With Inherited Cancer Syndrome
NA
Active, not recruiting
27,500 participants
Started: Mar 9, 2020 · Completed: Jun 10, 2030
6 conditions
3 sponsors
2 locations
NCT04296955
Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled Study
NA
Active, not recruiting
200 participants
Started: Mar 9, 2020 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT04225117
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
PHASE2
Active, not recruiting
329 participants
Started: Mar 9, 2020 · Completed: Sep 30, 2026
1 condition
3 sponsors
39 locations
NCT05374928
Human Epilepsy Project 3
N/A
Active, not recruiting
320 participants
Started: Mar 9, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT04137692
Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome
NA
Active, not recruiting
5 participants
Started: Mar 9, 2020 · Completed: Oct 31, 2028
2 conditions
1 sponsor
1 location
NCT04462393
Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19
N/A
Active, not recruiting
7,500 participants
Started: Mar 6, 2020 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04101903
Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice
NA
Active, not recruiting
172 participants
Started: Mar 6, 2020 · Completed: Jun 30, 2025
1 condition
6 sponsors
1 location
NCT03492944
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
N/A
Active, not recruiting
25 participants
Started: Mar 6, 2020 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT07027878
JETi Lower Extremity Venous Thrombosis
N/A
Active, not recruiting
121 participants
Started: Mar 6, 2020 · Completed: Aug 31, 2025
1 condition
1 sponsor
30 locations
NCT04537195
Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients
NA
Active, not recruiting
234 participants
Started: Mar 6, 2020 · Completed: Feb 1, 2026
8 conditions
4 sponsors
2 locations
NCT04296175
Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)
PHASE3
Active, not recruiting
808 participants
Started: Mar 5, 2020 · Completed: Mar 31, 2027
1 condition
1 sponsor
1 location
NCT06764550
Molecular and Microbiota Signatures Underlying Colonic Diverticular Disease
N/A
Active, not recruiting
150 participants
Started: Mar 5, 2020 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT04243616
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
PHASE2
Active, not recruiting
36 participants
Started: Mar 5, 2020 · Completed: Aug 12, 2030
1 condition
1 sponsor
1 location
NCT04123379
Neoadjuvant Nivolumab with CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
PHASE2
Active, not recruiting
48 participants
Started: Mar 5, 2020 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03274830
A Post Market Clinical Follow-up Study With the aneXys Cup
N/A
Active, not recruiting
102 participants
Started: Mar 5, 2020 · Completed: Sep 30, 2034
1 condition
1 sponsor
3 locations
NCT04215783
Childhood Allergy and the Neonatal Environment
N/A
Active, not recruiting
499 participants
Started: Mar 4, 2020 · Completed: Aug 31, 2026
2 conditions
4 sponsors
4 locations
NCT04000880
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
NA
Active, not recruiting
603 participants
Started: Mar 4, 2020 · Completed: Sep 1, 2025
9 conditions
3 sponsors
2 locations
NCT04294810
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
620 participants
Started: Mar 4, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
140 locations
NCT04217174
An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM
NA
Active, not recruiting
295 participants
Started: Mar 4, 2020 · Completed: Mar 30, 2025
2 conditions
5 sponsors
1 location
NCT04278781
AG-120 in People With IDH1 Mutant Chondrosarcoma
PHASE2
Active, not recruiting
6 participants
Started: Mar 4, 2020 · Completed: Mar 31, 2026
4 conditions
2 sponsors
5 locations
NCT03324425
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
PHASE2
Active, not recruiting
5 participants
Started: Mar 4, 2020 · Completed: Dec 31, 2030
1 condition
1 sponsor
2 locations
NCT04205838
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
PHASE2
Active, not recruiting
23 participants
Started: Mar 4, 2020 · Completed: Jun 30, 2027
11 conditions
1 sponsor
2 locations
NCT04298086
A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer
PHASE2
Active, not recruiting
43 participants
Started: Mar 4, 2020 · Completed: Mar 31, 2026
2 conditions
5 sponsors
7 locations
NCT04117945
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
22 participants
Started: Mar 3, 2020 · Completed: Mar 31, 2025
13 conditions
2 sponsors
15 locations
NCT03820141
Durvalumab with Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
PHASE2
Active, not recruiting
39 participants
Started: Mar 3, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04168008
A Peer-Led Intervention to Improve Postpartum Retention in HIV Care
NA
Active, not recruiting
151 participants
Started: Mar 3, 2020 · Completed: Sep 30, 2025
1 condition
2 sponsors
7 locations
NCT04262154
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
PHASE2
Active, not recruiting
28 participants
Started: Mar 3, 2020 · Completed: Sep 30, 2026
1 condition
3 sponsors
8 locations
NCT04567719
Measuring Taste Perception During Chemotherapy for Muscle Invasive Bladder Cancer
N/A
Active, not recruiting
9 participants
Started: Mar 3, 2020 · Completed: Dec 31, 2024
1 condition
2 sponsors
2 locations
NCT04399694
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders
N/A
Active, not recruiting
56 participants
Started: Mar 3, 2020 · Completed: Sep 30, 2027
5 conditions
1 sponsor
1 location
NCT04119687
Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee
PHASE1
Active, not recruiting
72 participants
Started: Mar 2, 2020 · Completed: Nov 28, 2026
1 condition
1 sponsor
6 locations
NCT04115033
Randomized Controlled Trial of CES for Fibromyalgia
NA
Active, not recruiting
50 participants
Started: Mar 2, 2020 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04091750
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
PHASE2
Active, not recruiting
14 participants
Started: Mar 2, 2020 · Completed: Dec 31, 2025
1 condition
4 sponsors
3 locations
NCT04287621
Registry of Asthma Patients Initiating DUPIXENT®
N/A
Active, not recruiting
718 participants
Started: Mar 2, 2020 · Completed: May 13, 2026
1 condition
2 sponsors
128 locations
NCT04395846
Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)
N/A
Active, not recruiting
350 participants
Started: Mar 2, 2020 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04289415
From Addiction to Employment.
NA
Active, not recruiting
200 participants
Started: Mar 1, 2020 · Completed: Feb 28, 2032
1 condition
3 sponsors
1 location
NCT04251117
GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects with Advanced HCC
PHASE1/PHASE2
Active, not recruiting
36 participants
Started: Mar 1, 2020 · Completed: Nov 29, 2028
1 condition
1 sponsor
3 locations
NCT05976048
Implementation of Actinic Keratosis Guideline Among General Practitioners.
N/A
Active, not recruiting
1,000 participants
Started: Mar 1, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04265222
Cam Decompression Utilizing the Stryker Hip-Check Software Platform
NA
Active, not recruiting
43 participants
Started: Mar 1, 2020 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT06418919
A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.
NA
Active, not recruiting
30 participants
Started: Mar 1, 2020 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT04227782
MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)
N/A
Active, not recruiting
40 participants
Started: Mar 1, 2020 · Completed: Oct 1, 2027
1 condition
1 sponsor
1 location
NCT04210115
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
PHASE3
Active, not recruiting
703 participants
Started: Feb 28, 2020 · Completed: Feb 1, 2027
3 conditions
1 sponsor
170 locations
NCT04281199
TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT
PHASE1
Active, not recruiting
20 participants
Started: Feb 28, 2020 · Completed: Jul 14, 2026
2 conditions
2 sponsors
1 location
NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
PHASE1/PHASE2
Active, not recruiting
1,410 participants
Started: Feb 28, 2020 · Completed: Jul 16, 2026
10 conditions
1 sponsor
109 locations
NCT04195750
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
PHASE3
Active, not recruiting
755 participants
Started: Feb 27, 2020 · Completed: Sep 17, 2026
1 condition
1 sponsor
172 locations
NCT04273594
FemBloc® Permanent Contraception - Confirmation Feasibility Trial
NA
Active, not recruiting
45 participants
Started: Feb 27, 2020 · Completed: Apr 30, 2027
1 condition
1 sponsor
6 locations
NCT04199689
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
PHASE3
Active, not recruiting
6,033 participants
Started: Feb 27, 2020 · Completed: Aug 31, 2028
1 condition
1 sponsor
103 locations
NCT03915431
A Study of NCS-01 in Patients With Acute Ischemic Stroke
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Feb 27, 2020 · Completed: Oct 31, 2028
1 condition
1 sponsor
1 location
NCT04095208
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study
PHASE2
Active, not recruiting
67 participants
Started: Feb 27, 2020 · Completed: Dec 31, 2026
2 conditions
2 sponsors
5 locations
NCT04140097
Predictors of Acute Exacerbation in Patients With COPD - an Observational Study
N/A
Active, not recruiting
355 participants
Started: Feb 26, 2020 · Completed: Apr 30, 2026
4 conditions
6 sponsors
1 location
NCT04189770
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
N/A
Active, not recruiting
200 participants
Started: Feb 26, 2020 · Completed: Feb 28, 2026
12 conditions
2 sponsors
1 location
Previous
1
More pages
285
286
287
288
289
290
291
More pages
431
Next